Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 108,793 |
|
|||||
| News | - | ||||||
| Day High | 8.74 | Low High |
|||||
| Day Low | 7.975 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Verrica Parmaceuticals Inc | VRCA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.44 | -5.14% | 8.12 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 8.56 | 7.975 | 8.74 | 8.12 | 8.56 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,258 | 108,793 | US$ 8.24 | US$ 896,514 | - | 2.86 - 11.41 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 16:03:39 | 1 | US$ 7.80 | USD |
Verrica Parmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 344.01M | 42.42M | - | 5.12M | -67M | -1.58 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Verrica Parmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 6/10/2024 | 15:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 6/07/2024 | 15:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 6/07/2024 | 15:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 5/15/2024 | 06:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 5/13/2024 | 15:31 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
| 5/13/2024 | 07:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/13/2024 | 06:46 | Edgar (US Regulatory) | Form 8-K - Current report |
| 2/29/2024 | 07:05 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 2/29/2024 | 06:45 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/08/2024 | 07:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/16/2023 | 15:49 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 11/16/2023 | 15:35 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRCA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.71 | 9.26 | 7.7334 | 8.58 | 159,166 | -0.59 | -6.77% |
| 1 Month | 9.25 | 9.395 | 7.7334 | 8.64 | 155,301 | -1.13 | -12.22% |
| 3 Months | 5.09 | 11.41 | 4.78 | 7.66 | 207,738 | 3.03 | 59.53% |
| 6 Months | 3.87 | 11.41 | 3.62 | 6.29 | 658,446 | 4.25 | 109.82% |
| 1 Year | 6.25 | 11.41 | 2.86 | 5.91 | 471,993 | 1.87 | 29.92% |
| 3 Years | 10.61 | 14.789 | 1.77 | 5.66 | 269,018 | -2.49 | -23.47% |
| 5 Years | 9.84 | 18.67 | 1.77 | 6.72 | 198,306 | -1.72 | -17.48% |
Verrica Parmaceuticals Description
| Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. |
